BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22878372)

  • 1. Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer.
    Harding V; Fenu E; Medani H; Shaboodien R; Ngan S; Li HK; Burt R; Diamantis N; Tuthill M; Blagden S; Gabra H; Urch CE; Moser S; Agarwal R
    Br J Cancer; 2012 Sep; 107(6):925-30. PubMed ID: 22878372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer.
    Sjoquist KM; Espinoza D; Mileshkin L; Ananda S; Shannon C; Yip S; Goh J; Bowtell D; Harrison M; Friedlander ML
    Gynecol Oncol; 2021 May; 161(2):374-381. PubMed ID: 33637349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Procedures for Malignant Ascites in a Palliative Care Outpatient Clinic.
    Korpi S; Salminen VV; Piili RP; Paunu N; Luukkaala T; Lehto JT
    J Palliat Med; 2018 Jun; 21(6):836-841. PubMed ID: 29489450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Low Volume Drainage of Ascites Associated With Improved Survival in Digestive System Cancer Patients With Malignant Ascites?-A Retrospective Cohort Study.
    Hoshino S; Takagi Y; Fukagawa T; Sano K; Seki N; Hashiguchi Y; Aruga E
    J Palliat Care; 2023 Oct; 38(4):473-480. PubMed ID: 37093798
    [No Abstract]   [Full Text] [Related]  

  • 5. Wall suction-assisted image-guided therapeutic paracentesis: a safe and less expensive alternative to evacuated bottles.
    Kelil T; Shyn PB; Wu LE; Levesque VM; Kacher D; Khorasani R; Silverman SG
    Abdom Radiol (NY); 2016 Jul; 41(7):1333-7. PubMed ID: 27315094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat Large-Volume Paracentesis Versus Tunneled Peritoneal Catheter Placement for Malignant Ascites: A Cost-Minimization Study.
    Bohn KA; Ray CE
    AJR Am J Roentgenol; 2015 Nov; 205(5):1126-34. PubMed ID: 26496562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Ultrasound-Guided Therapeutic Paracentesis in an Outpatient Transitional Care Program: A Case Series.
    Wang J; Khan S; Wyer P; Vanderwilp J; Reynolds J; Bethancourt B; Ota KS
    Am J Hosp Palliat Care; 2018 Sep; 35(9):1256-1260. PubMed ID: 29400065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
    Gaetano JN; Micic D; Aronsohn A; Reddy G; Te H; Reau NS; Jensen D
    J Gastroenterol Hepatol; 2016 May; 31(5):1025-30. PubMed ID: 26642977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer.
    Gotlieb WH; Feldman B; Feldman-Moran O; Zmira N; Kreizer D; Segal Y; Elran E; Ben-Baruch G
    Gynecol Oncol; 1998 Dec; 71(3):381-5. PubMed ID: 9887235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daycase trauma list: a safe and cost-effective service delivery.
    Athar MS; Fazal MA; Ashwood N; Arealis G; Buchanan D; Okoth FH
    Ann R Coll Surg Engl; 2019 Sep; 101(7):519-521. PubMed ID: 31155898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekend admissions with ascites are associated with delayed paracentesis: A nationwide analysis of the 'weekend effect'.
    Gupta K; Khan A; Goyal H; Cal N; Hans B; Martins T; Ghaoui R
    Ann Hepatol; 2020; 19(5):523-529. PubMed ID: 32540327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracentesis in ovarian cancer: a study of the physiology during free drainage of ascites.
    Decruze SB; Macdonald R; Smith G; Herod JJ
    J Palliat Med; 2010 Mar; 13(3):251-4. PubMed ID: 19929225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative long-term abdominal drains in refractory ascites due to end-stage liver disease: A case series.
    Macken L; Joshi D; Messenger J; Austin M; Tibble J; Mason L; Verma S
    Palliat Med; 2017 Jul; 31(7):671-675. PubMed ID: 27707955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites.
    Colombo N; Mangili G; Mammoliti S; Kalling M; Tholander B; Sternas L; Buzenet G; Chamberlain D
    Gynecol Oncol; 2012 Apr; 125(1):42-7. PubMed ID: 22112608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change?
    Fagan KJ; Zhao EY; Horsfall LU; Ruffin BJ; Kruger MS; McPhail SM; O'Rourke P; Ballard E; Irvine KM; Powell EE
    Intern Med J; 2014 Sep; 44(9):865-72. PubMed ID: 24893971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.
    Yokomichi N; Imai K; Sakamoto M; Horiki M; Yamauchi T; Miwa S; Inoue S; Uneno Y; Suzuki H; Wada T; Ichikawa Y; Morita T
    BMC Cancer; 2022 Feb; 22(1):218. PubMed ID: 35227250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MELD score and albumin replacement are related to higher costs during management of patients with refractory ascites.
    Borges de Santana V; Bertocco de Paiva Haddad L; Morgado Conte T; Cortez Rizzon A; Miranda Barbosa V; Shield W; Andraus W; Augusto Carneiro D'Albuquerque L
    Transplant Proc; 2014; 46(6):1760-3. PubMed ID: 25131030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative long-term abdominal drains versus repeated drainage in individuals with untreatable ascites due to advanced cirrhosis: study protocol for a feasibility randomised controlled trial.
    Macken L; Mason L; Evans C; Gage H; Jordan J; Austin M; Parnell N; Cooper M; Steer S; Boles J; Bremner S; Lambert D; Crook D; Earl G; Timeyin J; Verma S
    Trials; 2018 Jul; 19(1):401. PubMed ID: 30053891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis.
    Macken L; Bremner S; Gage H; Touray M; Williams P; Crook D; Mason L; Lambert D; Evans CJ; Cooper M; Timeyin J; Steer S; Austin M; Parnell N; Thomson SJ; Sheridan D; Wright M; Isaacs P; Hashim A; Verma S
    Aliment Pharmacol Ther; 2020 Jul; 52(1):107-122. PubMed ID: 32478917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central venous pressure catheter for large-volume paracentesis in refractory ascites.
    Agah S; Tavakoli S; Nikbakht H; Najafi M; Al-Agha A
    Indian J Gastroenterol; 2014 Jul; 33(4):310-5. PubMed ID: 24756422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.